Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 258917, 11 pages
http://dx.doi.org/10.1155/2014/258917
Review Article

New Insights into Monoclonal B-Cell Lymphocytosis

1Department of Haematology, University Hospital, University of Crete, P.O. BOX 1352, 71110 Heraklion, Crete, Greece
2Department of Haematology, Athens Medical Center-Psychikon Branch, 11525 Athens, Greece
3Department of Haematology, University of Athens, Laikon General Hospital, 11527 Athens, Greece
4Department of Pathology, University of Athens, 11527 Athens, Greece
5Department of Haematology, 401 Military Hospital, 11525 Athens, Greece
61st Department of Propedeutics, University of Athens, Laikon General Hospital, 11527 Athens, Greece

Received 17 April 2014; Accepted 21 July 2014; Published 11 September 2014

Academic Editor: Kazuyuki Shimizu

Copyright © 2014 Christina Kalpadakis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Han, H. Ozer, M. Gavigan et al., “Benign monoclonal B cell lymphocytosis. A benign variant of CLL: clinical, immunologic, phenotypic, and cytogenetic studies in 20 patients,” Blood, vol. 64, no. 1, pp. 244–252, 1984. View at Google Scholar · View at Scopus
  2. E. Kimby, H. Mellstedt, M. Bjorkholm, and G. Holm, “Clonal cell surface structures related to differentiation, activation and homing in B-cell chronic lymphocytic leukemia and monoclonal lymphocytosis undetermined significance,” European Journal of Haematology, vol. 43, no. 5, pp. 452–459, 1989. View at Google Scholar · View at Scopus
  3. W. G. Nieto, J. Almeida, A. Romero et al., “Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach,” Blood, vol. 114, no. 1, pp. 33–37, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. C. Rawstron, M. J. Green, A. Kuzmicki et al., “Monoclonal B lymphocytes with the characteristics of “indolent” chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts,” Blood, vol. 100, no. 2, pp. 635–639, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Ghia, G. Prato, C. Scielzo et al., “Monoclonal CD5+ and CD5- B-lymphocyte expansions are frequent in the peripheral blood of the elderly,” Blood, vol. 103, no. 6, pp. 2337–2342, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Scarfò, A. Dagklis, C. Scielzo, C. Fazi, and P. Ghia, “CLL-like monoclonal B-cell lymphocytosis: are we all bound to have it?” Seminars in Cancer Biology, vol. 20, no. 6, pp. 384–390, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Almeida, W. G. Nieto, C. Teodosio et al., “CLL-like B-lymphocytes are systematically present at very low numbers in peripheral blood of healthy adults,” Leukemia, vol. 25, no. 4, pp. 718–722, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. G. E. Marti, A. C. Rawstron, P. Ghia et al., “Diagnostic criteria for monoclonal B-cell lymphocytosis,” British Journal of Haematology, vol. 130, no. 3, pp. 325–332, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. K. Shim, R. F. Vogt, D. Middleton et al., “Prevalence and natural history of monoclonal and polyclonal B-cell lymphocytosis in a residential adult population,” Cytometry B—Clinical Cytometry, vol. 72, no. 5, pp. 344–353, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Rachel, M. L. Zucker, C. M. Fox et al., “Monoclonal B-cell lymphocytosis in blood donors,” British Journal of Haematology, vol. 139, no. 5, pp. 832–836, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. A. C. Rawstron, F. L. Bennett, S. J. M. O'Connor et al., “Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 359, no. 6, pp. 575–583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Dagklis, C. Fazi, C. Sala et al., “The immunoglobulin gene repertoire of low-count chronic lymphocytic leukemia (CLL)-like monoclonal B lymphocytosis is different from CLL: diagnostic implications for clinical monitoring,” Blood, vol. 114, no. 1, pp. 26–32, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. K. Shim, J. M. Rachel, P. Ghia et al., “Monoclonal B-cell lymphocytosis in healthy blood donors: an unexpectedly common finding,” Blood, vol. 123, no. 9, pp. 1319–1326, 2014. View at Publisher · View at Google Scholar
  14. D. M. Matos, S. J. Ismael, C. A. Scrideli, F. M. de Oliveira, E. M. Rego, and R. P. Falcão, “Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 147, no. 3, pp. 339–346, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. G. E. Marti, P. Carter, F. Abbasi et al., “B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia,” Cytometry B: Clinical Cytometry, vol. 52, no. 1, pp. 1–12, 2003. View at Google Scholar · View at Scopus
  16. A. C. Rawstron, M. R. Yuille, J. Fuller et al., “Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion,” Blood, vol. 100, no. 7, pp. 2289–2291, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. T. D. Shanafelt, N. E. Kay, G. Jenkins et al., “B-cell count and survival: differentiating chronic lymphocytic leukemia from monoclonal B-cell lymphocytosis based on clinical outcome,” Blood, vol. 113, no. 18, pp. 4188–4196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Rossi, E. Sozzi, A. Puma et al., “The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors,” British Journal of Haematology, vol. 146, no. 1, pp. 64–75, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. L. Scarfo, S. Zibellini, A. Tedeschi et al., “Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines,” Leukemia, vol. 26, no. 7, pp. 1703–1707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. A. C. Rawstron, T. Shanafelt, M. C. Lanasa et al., “Different biology and clinical outcome according to the absolute numbers of clonal B-cells in monoclonal B-cell lymphocytosis (MBL),” Cytometry Part B: Clinical Cytometry, vol. 78, supplement 1, pp. S19–S23, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. T. D. Shanafelt, P. Ghia, M. C. Lanasa, O. Landgren, and A. C. Rawstron, “Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management,” Leukemia, vol. 24, no. 3, pp. 512–520, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Lanasa, S. D. Allgood, A. D. Volkheimer et al., “Single-cell analysis reveals oligoclonality among low-count monoclonal B-cell lymphocytosis,” Leukemia, vol. 24, no. 1, pp. 133–140, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Henriques, A. Rodríguez-Caballero, I. Criado et al., “Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders,” Haematologica, vol. 99, no. 5, pp. 897–907, 2014. View at Google Scholar
  24. S. S. Fung, K. L. Hillier, C. S. Leger et al., “Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis,” Leukemia and Lymphoma, vol. 48, no. 6, pp. 1087–1091, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Kern, U. Bacher, C. Haferlach et al., “Monoclonal B-cell lymphocytosis is closely related to chronic lymphocytic leukaemia and may be better classified as early-stage CLL,” British Journal of Haematology, vol. 157, no. 1, pp. 86–96, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. T. D. Shanafelt, N. E. Kay, K. G. Rabe et al., “Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia,” Journal of Clinical Oncology, vol. 27, no. 24, pp. 3959–3963, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. C. S. Mulligan, M. E. Thomas, and S. P. Mulligan, “Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 359, no. 19, pp. 2065–2066, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. T. D. Shanafelt, N. E. Kay, T. G. Call et al., “MBL or CLL: Which classification best categorizes the clinical course of patients with an absolute lymphocyte count  5 × 109 L-1 but a B-cell lymphocyte count < 5 × 109 L-1?” Leukemia Research, vol. 32, no. 9, pp. 1458–1461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Molica, M. Gentile, F. R. Mauro et al., “An increased number of individuals with clinically recognized monoclonal B-cell lymphocytosis characterizes a recent database of chronic lymphocytic leukemia Rai stage 0,” Acta Haematologica, vol. 127, no. 3, pp. 149–151, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Molica, F. R. Mauro, M. Molica, I. D. Giudice, and R. Foà, “Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications,” Leukemia and Lymphoma, vol. 53, no. 9, pp. 1660–1665, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. A. C. Rawstron, “Monoclonal B-cell lymphocytosis,” Hematology, pp. 430–439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. J. Moreira, K. G. Rabe, J. R. Cerhan et al., “Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controls,” Leukemia, vol. 27, no. 1, pp. 136–141, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Fazi, L. Scarfò, L. Pecciarini et al., “General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL,” Blood, vol. 118, no. 25, pp. 6618–6625, 2011. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Vardi, A. Dagklis, L. Scarfò et al., “Immunogenetics shows that not all MBL are equal: the larger the clone, the more similar to CLL,” Blood, vol. 121, no. 22, pp. 4521–4528, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Henriques, A. Rodríguez-Caballero, W. G. Nieto et al., “Combined Patterns of IGHV Repertoire and Cytogenetic/Molecular Alterations in Monoclonal B Lymphocytosis versus Chronic Lymphocytic Leukemia,” PLoS ONE, vol. 8, no. 7, Article ID e67751, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Ghia, G. Prato, S. Stella, C. Scielzo, M. Geuna, and F. Caligaris-Cappio, “Age-dependent accumulation of monoclonal CD4+CD8 +double positive T lymphocytes in the peripheral blood of the elderly,” British Journal of Haematology, vol. 139, no. 5, pp. 780–790, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. W. Hauswirth, J. Almeida, W. G. Nieto et al., “Monoclonal B-cell lymphocytosis (MBL) with normal lymphocyte counts is associated with decreased numbers of normal circulating B-cell subsets,” The American Journal of Hematology, vol. 87, no. 7, pp. 721–724, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. U. Randen, A. M. Tierens, G. E. Tjonnfjord, and J. Delabie, “Bone Marrow histology in monoclonal b-cell lymphocytosis shows various b-cell infiltration patterns,” The American Journal of Clinical Pathology, vol. 139, no. 3, pp. 390–395, 2013. View at Publisher · View at Google Scholar · View at Scopus
  39. M. C. Lanasa, S. D. Allgood, S. L. Slager et al., “Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL,” Leukemia, vol. 25, no. 9, pp. 1459–1466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. Quijano, A. López, A. Rasillo et al., “Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia,” Cytometry B—Clinical Cytometry, vol. 74, no. 3, pp. 139–149, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Ghia and F. Caligaris-Cappio, “Monoclonal B-cell lymphocytosis: right track or red herring?” Blood, vol. 119, no. 19, pp. 4358–4362, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. P. Ghia, F. Melchers, and A. G. Rolink, “Age-dependent changes in B lymphocyte development in man and mouse,” Experimental Gerontology, vol. 35, no. 2, pp. 159–165, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. A. Agathangelidis, N. Darzentas, A. Hadzidimitriou et al., “Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies,” Blood, vol. 119, no. 19, pp. 4467–4475, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. D. Casabonne, J. Almeida, W. G. Nieto et al., “Common infectious agents and monoclonal B-cell lymphocytosis: a cross- sectional epidemiological study among healthy adults,” PLoS ONE, vol. 7, no. 12, Article ID e52808, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. L. A. Anderson, O. Landgren, and E. A. Engels, “Common community acquired infections and subsequent risk of chronic lymphocytic leukaemia,” British Journal of Haematology, vol. 147, no. 4, pp. 444–449, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. G. Fabbri, S. Rasi, D. Rossi et al., “Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation,” Journal of Experimental Medicine, vol. 208, no. 7, pp. 1389–1401, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Rossi, A. Bruscaggin, V. Spina et al., “Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness,” Blood, vol. 118, no. 26, pp. 6904–6908, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. D. Rossi, M. Fangazio, S. Rasi et al., “Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia,” Blood, vol. 119, no. 12, pp. 2854–2862, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Greco, D. Capello, A. Bruscaggin et al., “Analysis of SF3B1 mutations in monoclonal B-cell lymphocytosis,” Hematological Oncology, vol. 31, no. 1, pp. 54–55, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Foà, I. del Giudice, A. Guarini, D. Rossi, and G. Gaidano, “Clinical implications of the molecular genetics of chronic lymphocytic leukemia,” Haematologica, vol. 98, no. 5, pp. 675–685, 2013. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Lionetti, S. Fabris, G. Cutrona et al., “High-throughput sequencing for the identification of NOTCH1 mutations in early stage chronic lymphocytic leukaemia: biological and clinical implications,” British Journal of Haematology, vol. 165, no. 5, pp. 629–639, 2014. View at Google Scholar
  52. G. A. Calin, M. Ferracin, A. Cimmino et al., “A microRNA signature associated with prognosis and progression in chronic lymphocytic leukemia,” The New England Journal of Medicine, vol. 353, no. 17, pp. 1793–1801, 2005. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Ferrajoli, T. D. Shanafelt, C. I. Masayoshi Shimizu et al., “Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia,” Blood, vol. 122, pp. 1891–1899, 2013. View at Google Scholar
  54. A. Henriques, A. Rodriguez-Caballero, I. Criado et al., “Molecular and cytogenetic characterization of expanded B-cell clones from multiclonal versus monoclonal B-cell chronic lymphoproliferative disorders,” Haematologica, vol. 99, no. 5, pp. 897–907, 2014. View at Publisher · View at Google Scholar
  55. G. A. Pangalis, V. A. Boussiotis, and C. Kittas, “Malignant disorders of small lymphocytes: small lymphocytic lymphoma, lymphoplasmacytic lymphoma, and chronic lymphocytic leukemia: their clinical and laboratory relationship,” The American Journal of Clinical Pathology, vol. 99, no. 4, pp. 402–408, 1993. View at Google Scholar · View at Scopus
  56. M. Stetler-Stevenson, “Monoclonal B-cell lymphocytosis in donors,” Blood, vol. 123, pp. 1281–1282, 2014. View at Google Scholar
  57. J. J. Castillo, S. Dalia, and S. K. Pascual, “Association between red blood cell transfusions and development of non-Hodgkin lymphoma: a meta-analysis of observational studies,” Blood, vol. 116, no. 16, pp. 2897–2907, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. N. M. Hardy, C. Grady, R. Pentz et al., “Bioethical considerations of monoclonal B-cell lymphocytosis: donor transfer after haematopoietic stem cell transplantation,” British Journal of Haematology, vol. 139, no. 5, pp. 824–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  59. W. G. Nieto, C. Teodosio, A. López et al., “Primary Health Care Group of Salamanca for the Study of MBL: non- CLL-like monoclonal B-cell lymphocytosis in the general population: prevalence and phenotypic/genetic characteristics,” Cytometry Part B: Clinical Cytometry, vol. 78, supplement 1, pp. S24–S34, 2010. View at Publisher · View at Google Scholar
  60. D. Amato, D. G. Oscier, Z. Davis et al., “Cytogenetic aberrations and immunoglobulin VH gene mutations in clinically benign CD5- monoclonal B-cell lymphocytosis,” The American Journal of Clinical Pathology, vol. 128, no. 2, pp. 333–338, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Kalpadakis, G. A. Pangalis, S. Sachanas et al., “Primary bone marrow marginal zone lymphoma (PBMMZL): a new disease entity?” Haematologica, vol. 95, no. 2, p. 109, 2010. View at Google Scholar
  62. C. Kalpadakis, G. Pangalis, S. Sachanas et al., “Comparative study of splenic marginal zone lymphoma (SMZL) and primary bone marrow MZL (PBMMZL),” Haematologica, vol. 96, no. 2, p. p392, 2011. View at Google Scholar
  63. C. Kalpadakis, G. A. Pangalis, T. P. Vassilakopoulos et al., “CD5-monoclonal B-cell lymphoproliferation (MBL): clinical characteristics and outcome,” Haematologica, vol. 97, no. s1, p. p86, 2012. View at Google Scholar
  64. F. Berger, P. Felman, C. Thieblemont et al., “Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients,” Blood, vol. 95, no. 6, pp. 1950–1956, 2000. View at Google Scholar · View at Scopus
  65. A. Xochelli, C. Kalpadakis, A. Gardiner et al., “Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity?” Blood, vol. 123, no. 8, pp. 1199–1206, 2014. View at Google Scholar